Skip to main content
BMA
NYSE Finance

Major Shareholder FGS-ANSES to Use Cumulative Voting for Director Appointments

Analysis by Wiseek AI
Sentiment info
Neutral
Importance info
7
Price
$71.23
Mkt Cap
$4.676B
52W Low
$38.3
52W High
$106.15
Market data snapshot near publication time

Summary

A major shareholder, FGS-ANSES, announced its intent to use cumulative voting for director appointments, signaling increased shareholder engagement in governance.


Key Events

  • Shareholder Voting Intent

    FGS-ANSES, a significant shareholder, notified Macro Bank of its decision to use cumulative voting for the appointment of regular and alternate directors and members of the Supervisory Committee.

  • Upcoming Shareholders' Meeting

    The General Shareholders' Meeting is scheduled for April 8, 2026, where these appointments will be made.

  • Governance Implications

    Cumulative voting is a mechanism that allows for greater minority shareholder representation, potentially influencing future board composition and strategic direction.


Analysis

This filing indicates that FGS-ANSES, a significant shareholder, intends to utilize cumulative voting for the election of directors and supervisory committee members at the upcoming General Shareholders' Meeting. Cumulative voting allows shareholders to concentrate their votes, increasing the likelihood of minority representation on the board. This move signals a proactive stance by FGS-ANSES to ensure its interests are represented and could influence future governance and strategic decisions at Macro Bank.

At the time of this filing, BMA was trading at $71.23 on NYSE in the Finance sector, with a market capitalization of approximately $4.7B. The 52-week trading range was $38.30 to $106.15. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BMA - Latest Insights

BMA
Jun 04, 2026, 4:11 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $87.01
Real-time Price: $98.71 info
Change: +$11.70 (+13%) info
Market Cap: $6.564B info
BMA
May 27, 2026, 5:07 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $85.26
Real-time Price: $98.71 info
Change: +$13.45 (+16%) info
Market Cap: $6.564B info
BMA
May 27, 2026, 4:39 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $85.26
Real-time Price: $98.71 info
Change: +$13.45 (+16%) info
Market Cap: $6.564B info
BMA
May 20, 2026, 10:57 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $70.45
Real-time Price: $98.71 info
Change: +$28.26 (+40%) info
Market Cap: $6.564B info
BMA
May 06, 2026, 4:26 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $76.97
Real-time Price: $98.71 info
Change: +$21.74 (+28%) info
Market Cap: $6.564B info
BMA
Apr 20, 2026, 3:48 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $82.63
Real-time Price: $98.71 info
Change: +$16.08 (+19%) info
Market Cap: $6.564B info
BMA
Apr 08, 2026, 11:42 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $80.39
Real-time Price: $98.71 info
Change: +$18.32 (+23%) info
Market Cap: $6.564B info
BMA
Mar 20, 2026, 4:23 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $67.69
Real-time Price: $98.71 info
Change: +$31.02 (+46%) info
Market Cap: $6.564B info
BMA
Mar 20, 2026, 9:10 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $69.12
Real-time Price: $98.71 info
Change: +$29.59 (+43%) info
Market Cap: $6.564B info
BMA
Mar 09, 2026, 4:14 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $71.23
Real-time Price: $98.71 info
Change: +$27.48 (+39%) info
Market Cap: $6.564B info